391 related articles for article (PubMed ID: 6339961)
21. Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients.
Ho CL; Chen YC; Kao WY; Chao TY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):45-52. PubMed ID: 10645050
[TBL] [Abstract][Full Text] [Related]
22. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen.
Poplack DG; Reaman GH; Wesley R
Cancer Treat Rep; 1981; 65 Suppl 4():93-6. PubMed ID: 6955015
[TBL] [Abstract][Full Text] [Related]
23. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
[TBL] [Abstract][Full Text] [Related]
24. [Long-term follow-up of 2 therapeutic programs for the treatment of high-risk childhood acute lymphoblastic leukemia. Experience at the 20 de Noviembre National Medical Center].
de Diego-Floreschapa J; López-Hernández M; Borbolla-Escoboza JR; Trueba-Christy E; Carrillo-Rosales T; González-Avante M
Gac Med Mex; 1999; 135(3):253-8. PubMed ID: 10425822
[TBL] [Abstract][Full Text] [Related]
25. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
[TBL] [Abstract][Full Text] [Related]
26. Antimetaboliths in the prophylaxis and treatment of central nervous system leukemia.
Haghbin M
Cancer Treat Rep; 1977 Jul; 61(4):661-6. PubMed ID: 267507
[TBL] [Abstract][Full Text] [Related]
27. Reinduction therapy for adult acute leukemia with adriamycin, vincristine, and prednisone: a Southwest Oncology Group study.
Elias L; Shaw MT; Raab SO
Cancer Treat Rep; 1979 Aug; 63(8):1413-5. PubMed ID: 289442
[TBL] [Abstract][Full Text] [Related]
28. Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study.
Rivera GK; Buchanan G; Boyett JM; Camitta B; Ochs J; Kalwinsky D; Amylon M; Vietti TJ; Crist WM
N Engl J Med; 1986 Jul; 315(5):273-8. PubMed ID: 3523250
[TBL] [Abstract][Full Text] [Related]
29. [Acute lymphoblastic leukemia of high risk: results of a therapeutic protocol].
Castel V; Verdeguer A; Ferris J; Esquembre C
An Esp Pediatr; 1987 Nov; 27(5):331-4. PubMed ID: 3481522
[TBL] [Abstract][Full Text] [Related]
30. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157
[TBL] [Abstract][Full Text] [Related]
31. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
[TBL] [Abstract][Full Text] [Related]
32. Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881.
Hutchinson RJ; Gaynon PS; Sather H; Bertolone SJ; Cooper HA; Tannous R; Wells LM; Heerema NA; Sailer S; Trigg ME;
J Clin Oncol; 2003 May; 21(9):1790-7. PubMed ID: 12721256
[TBL] [Abstract][Full Text] [Related]
33. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
Lange BJ; Blatt J; Sather HN; Meadows AT
Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
[TBL] [Abstract][Full Text] [Related]
34. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.
Anderson J; Krivit W; Chilcote R; Pyesmany A; Chard R; Hammond D
Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911
[TBL] [Abstract][Full Text] [Related]
36. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults.
Yap BS; McCredie KB; Keating MJ; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65 Suppl 1():83-7. PubMed ID: 6948610
[TBL] [Abstract][Full Text] [Related]
37. [Multiple agent cyclic chemotherapy in the treatment of acute lymphoblastic leukemia of children ("C"-protocol) (author's transl)].
Ortega Aramburu JJ; Javier G; Sáenz A; Tusell J
An Esp Pediatr; 1976 Jun; 9(4 Suppl):49-54. PubMed ID: 782307
[TBL] [Abstract][Full Text] [Related]
38. [Acute lymphoblastic leukemia of standard risk: preliminary results obtained with protocol LL-IV-81].
Verdeguer Miralles A; Castel Sánchez V; Ferris Tortajada J; Esquembre Menor C
An Esp Pediatr; 1987 Nov; 27(5):325-30. PubMed ID: 3481521
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of high and low risk acute lymphoblastic leukemias in the child, with 2 modalities of preventive therapy on the central nervous system (Pethema 7/78 protocol)].
Ortega Aramburu JJ; Javier G; Montagut JM; Torán N
An Esp Pediatr; 1985 Nov; 23(6):417-30. PubMed ID: 3867301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
